Dianthus Therapeutics Inc. (DNTH)
NASDAQ · Healthcare
Dianthus Therapeutics Inc. Total Liabilities 2016–2025
Dianthus Therapeutics Inc. annual/quarterly total liabilities history from 2017 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Dianthus Therapeutics Inc. total liabilities for the quarter ending December 31, 2025 were 37.5M, a 74.27% increase year-over-year.
- Dianthus Therapeutics Inc. total liabilities for 2025 were 37.5M, a 74.27% increase from 2024.
- Dianthus Therapeutics Inc. total liabilities for 2024 were 21.5M, a 104.38% increase from 2023.
- Dianthus Therapeutics Inc. total liabilities for 2023 were 10.5M, a 48.16% decrease from 2019.
- Dianthus Therapeutics Inc. total liabilities for 2019 were 20.3M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Dianthus Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $38 |
| 2024 | $22 |
| 2023 | $11 |
| 2019 | $20 |
| 2018 | $12 |
| 2017 | $4 |
| Dianthus Therapeutics Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $38 |
| 2024-12-31 | $22 |
| 2023-12-31 | $11 |
| 2019-12-31 | $20 |
| 2018-12-31 | $12 |
| 2017-12-31 | $4 |
Dianthus Therapeutics Inc. Total Liabilities — FAQ
Dianthus Therapeutics Inc. (DNTH) total liabilities over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see DNTH's total liabilities history?
The chart and table above show Dianthus Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.